A citation-based method for searching scientific literature

Youchao Xiao, Gang Cui, Xingguang Ren, Jiaqi Hao, Yu Zhang, Xin Yang, Zhuangzhuang Wang, Xiaolin Zhu, Huan Wang, Chunyan Hao, Hubin Duan. Front Oncol 2020
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
66

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
66

A history of exploring cancer in context.
Shelly Maman, Isaac P Witz. Nat Rev Cancer 2018
148
33


The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
Franck Pagès, Julien Taieb, Pierre Laurent-Puig, Jérôme Galon. Oncoimmunology 2020
3
33

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours.
Nina Linder, Jenny C Taylor, Richard Colling, Robert Pell, Edward Alveyn, Johnson Joseph, Andrew Protheroe, Mikael Lundin, Johan Lundin, Clare Verrill. J Clin Pathol 2019
19
33

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer.
Kenneth Emancipator, Lingkang Huang, Deepti Aurora-Garg, Tricia Bal, Ezra E W Cohen, Kevin Harrington, Denis Soulières, Christophe Le Tourneau, Lisa Licitra, Barbara Burtness,[...]. Mod Pathol 2021
8
33

Big opportunities for small molecules in immuno-oncology.
Jerry L Adams, James Smothers, Roopa Srinivasan, Axel Hoos. Nat Rev Drug Discov 2015
217
33

The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
Matthew P Humphries, Stephanie G Craig, Rafal Kacprzyk, Natalie C Fisher, Victoria Bingham, Stephen McQuaid, Graeme I Murray, Damian McManus, Richard C Turkington, Jacqueline James,[...]. BMC Cancer 2020
11
33

Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.
Nicolas A Giraldo, J David Peske, Catherine Sautès-Fridman, Wolf H Fridman. Virchows Arch 2019
9
33

Biopsy quality is essential for preoperative prognostication in oral tongue cancer.
Ibrahim O Bello, Pia M Wennerstrand, Ilida Suleymanova, Maria Siponen, Ahmed Qannam, Pentti Nieminen, Ilmo Leivo, Alhadi Almangush, Tuula Salo. APMIS 2021
2
50


Stromal categorization in early oral tongue cancer.
Alhadi Almangush, Ibrahim O Bello, Ilkka Heikkinen, Jaana Hagström, Caj Haglund, Luiz Paulo Kowalski, Pentti Nieminen, Ricardo D Coletta, Antti A Mäkitie, Tuula Salo,[...]. Virchows Arch 2021
3
33

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, S Wienert, G Van den Eynden, F L Baehner, F Penault-Llorca,[...]. Ann Oncol 2015
33

Immunotherapy for head and neck cancer: Recent advances and future directions.
John D Cramer, Barbara Burtness, Robert L Ferris. Oral Oncol 2019
68
33

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.
Spencer C Wei, Colm R Duffy, James P Allison. Cancer Discov 2018
33

Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
John H Strickler, Brent A Hanks, Mustafa Khasraw. Clin Cancer Res 2021
30
33

Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
Chen Zhou, Pengfei Diao, Yaping Wu, Zicheng Wei, Lei Jiang, Wei Zhang, Zhongwu Li, Jinhai Ye, Xiaomeng Song, Heming Wu,[...]. Int J Cancer 2020
8
33

The clinical role of the TME in solid cancer.
Nicolas A Giraldo, Rafael Sanchez-Salas, J David Peske, Yann Vano, Etienne Becht, Florent Petitprez, Pierre Validire, Alexandre Ingels, Xavier Cathelineau, Wolf Herman Fridman,[...]. Br J Cancer 2019
109
33

Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma.
Chungsu Hwang, So Jung Lee, Jung Hee Lee, Ki Hyung Kim, Dong Soo Suh, Byung-Su Kwon, Kyung Un Choi. Oncol Lett 2019
6
33

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.
Daniela Bruni, Helen K Angell, Jérôme Galon. Nat Rev Cancer 2020
167
33

Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.
Alhadi Almangush, Ilkka Heikkinen, Antti A Mäkitie, Ricardo D Coletta, Esa Läärä, Ilmo Leivo, Tuula Salo. Br J Cancer 2017
78
33

Immune checkpoint inhibitors win the 2018 Nobel Prize.
Pei-Wei Huang, John Wen-Cheng Chang. Biomed J 2019
16
33





A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.
Muhammad Shaban, Syed Ali Khurram, Muhammad Moazam Fraz, Najah Alsubaie, Iqra Masood, Sajid Mushtaq, Mariam Hassan, Asif Loya, Nasir M Rajpoot. Sci Rep 2019
32
33

Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Dan P Zandberg, Alain P Algazi, Antonio Jimeno, James S Good, Jérôme Fayette, Nathaniel Bouganim, Neal E Ready, Paul M Clement, Caroline Even, Raymond W Jang,[...]. Eur J Cancer 2019
89
33

Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 Patients.
Talia L Fuchs, Loretta Sioson, Amy Sheen, Kambin Jafari-Nejad, Christopher J Renaud, Juliana Andrici, Mahsa Ahadi, Angela Chou, Anthony J Gill. Am J Surg Pathol 2020
19
33

Independent Prognostic Value of Intratumoral Heterogeneity and Immune Response Features by Automated Digital Immunohistochemistry Analysis in Early Hormone Receptor-Positive Breast Carcinoma.
Dovile Zilenaite, Allan Rasmusson, Renaldas Augulis, Justinas Besusparis, Aida Laurinaviciene, Benoit Plancoulaine, Valerijus Ostapenko, Arvydas Laurinavicius. Front Oncol 2020
5
33

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
Robert L Ferris, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Lisa Licitra, Kevin Harrington, Stefan Kasper, Everett E Vokes, Caroline Even,[...]. N Engl J Med 2016
33


Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.
Yejinpeng Wang, Liang Chen, Mengxue Yu, Yayun Fang, Kaiyu Qian, Gang Wang, Lingao Ju, Yu Xiao, Xinghuan Wang. Cancer Med 2020
6
33

The prognostic role of tumour-infiltrating lymphocytes in oral squamous cell carcinoma: A meta-analysis.
Zhengxian Huang, Nan Xie, Haichao Liu, Yuehan Wan, Yue Zhu, Ming Zhang, Yifan Tao, Han Zhou, Xiqiang Liu, Jinsong Hou,[...]. J Oral Pathol Med 2019
19
33

Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Marlon C Rebelatto, Anita Midha, Amita Mistry, Constantine Sabalos, Nicole Schechter, Xia Li, Xiaoping Jin, Keith E Steele, Paul B Robbins, John A Blake-Haskins,[...]. Diagn Pathol 2016
127
33

Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.
Razvan Cristescu, Robin Mogg, Mark Ayers, Andrew Albright, Erin Murphy, Jennifer Yearley, Xinwei Sher, Xiao Qiao Liu, Hongchao Lu, Michael Nebozhyn,[...]. Science 2018
710
33

Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
Margaret Brandwein-Gensler, Miriam S Teixeira, Carol Ming Lewis, Bryant Lee, Linda Rolnitzky, Johannes J Hille, Eric Genden, Mark L Urken, Beverly Yiyao Wang. Am J Surg Pathol 2005
468
33

A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer.
Inger-Heidi Bjerkli, Elin Hadler-Olsen, Elisabeth Sivy Nginamau, Helene Laurvik, Tine M Søland, Daniela Elena Costea, Lars Uhlin-Hansen, Sonja E Steigen. Virchows Arch 2020
2
50

Digital Image Analysis of CD8+ and CD3+ Tumor-Infiltrating Lymphocytes in Tongue Squamous Cell Carcinoma.
Yenlin Huang, Chieh Lin, Huang-Kai Kao, Shao-Yu Hung, Hung-Ju Ko, Yu-Chen Huang, Yu-Liang Chang, Kai-Ping Chang. Cancer Manag Res 2020
6
33

The prognostic value of immune checkpoints in oral squamous cell carcinoma.
Meri Sieviläinen, Rabeia Almahmoudi, Ahmed Al-Samadi, Tuula Salo, Matti Pirinen, Alhadi Almangush. Oral Dis 2019
19
33

The immune contexture in cancer prognosis and treatment.
Wolf H Fridman, Laurence Zitvogel, Catherine Sautès-Fridman, Guido Kroemer. Nat Rev Clin Oncol 2017
762
33

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma.
M Oliva, A Spreafico, M Taberna, L Alemany, B Coburn, R Mesia, L L Siu. Ann Oncol 2019
64
33

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial.
Jonathan D Schoenfeld, Glenn J Hanna, Vickie Y Jo, Bhupendra Rawal, Yu-Hui Chen, Paul S Catalano, Ana Lako, Zoe Ciantra, Jason L Weirather, Shana Criscitiello,[...]. JAMA Oncol 2020
37
33

Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.
César Rivera, Ana Karina Oliveira, Rute Alves Pereira Costa, Tatiane De Rossi, Adriana Franco Paes Leme. Oral Oncol 2017
81
33

Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
Edwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, Heather Lin, Barbara Mino, Jorge Blando, Jianjun Zhang, Don L Gibbons, John V Heymach, Boris Sepesi,[...]. Clin Cancer Res 2016
88
33


Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.
Laura Q M Chow, Robert Haddad, Shilpa Gupta, Amit Mahipal, Ranee Mehra, Makoto Tahara, Raanan Berger, Joseph Paul Eder, Barbara Burtness, Se-Hoon Lee,[...]. J Clin Oncol 2016
456
33

Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors.
Dan Sha, Zhaohui Jin, Jan Budczies, Klaus Kluck, Albrecht Stenzinger, Frank A Sinicrope. Cancer Discov 2020
37
33

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.
Yi Liu-Chittenden, Bo Huang, Joong Sup Shim, Qian Chen, Se-Jin Lee, Robert A Anders, Jun O Liu, Duojia Pan. Genes Dev 2012
789
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.